Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06502067Not yet recruiting
Randomised, double-blind trial of bupivacaine in perioperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Total perioperative analgesia consumption throughout 24 hours. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06502067.